Eva Szabo

Title: Eva Szabo: Innovator in Pharmaceutical Chemistry

Introduction

Eva Szabo is a distinguished inventor based in Budapest, Hungary. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the preparation of active pharmaceutical ingredients. With a total of two patents to her name, her work has had a notable impact on the industry.

Latest Patents

Eva Szabo's latest patents include a process for the preparation of vortioxetine salts. This invention relates to an improved method for creating pharmaceutical active ingredients, specifically focusing on high purity salts and pharmaceutical compositions. The process is designed to be economical and efficient, particularly for the compound known as vortioxetine, which has the chemical nomenclature 1-[2-(2,4-dimethyl-phenylsulfanyl)-phenyl]-piperazine. Additionally, she has developed a new and improved process for the preparation of 6,7-dichloro-1,5-dihydroimidazo[2,1-b]-quinazolin-2[3H]-one, also known as anagrelide. This valuable compound serves as a blood platelet antiaggregative agent and is produced through a thermal cyclization process in an acidic medium.

Career Highlights

Throughout her career, Eva Szabo has worked with notable companies such as Egis Gyógyszergyár and Egis Gyógyszergyár Zrt. Her expertise in pharmaceutical processes has positioned her as a key player in the development of innovative solutions in the industry.

Collaborations

Eva has collaborated with esteemed colleagues, including Jozsef Reiter and Peter Trinka. These partnerships have further enhanced her research and development efforts in pharmaceutical chemistry.

Conclusion

Eva Szabo's contributions to pharmaceutical chemistry through her innovative patents and collaborations highlight her role as a leading inventor in the field. Her work continues to influence the development of important pharmaceutical compounds.